p62/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis

Author： Nogalska Anna  

Publisher： Springer Publishing Company

ISSN： 0001-6322

Source： Acta Neuropathologica, Vol.118, Iss.3, 2009-09, pp. : 407-413

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dysferlin is a newly identified binding partner of AβPP and it co-aggregates with amyloid-β42 within sporadic inclusion-body myositis (s-IBM) muscle fibers

By Cacciottolo Mafalda   Nogalska Anna   D’Agostino Carla   Engel W.   Askanas Valerie  

Acta Neuropathologica, Vol. 126, Iss. 5, 2013-11 ,pp. : 781-783

Springer Publishing Company

Access to resources Recommend Favorite

Pilot trial of simvastatin in the treatment of sporadic inclusion-body myositis

By Sancricca Cristina  

Neurological Sciences, Vol. 32, Iss. 5, 2011-10 ,pp. : 841-847

Springer Publishing Company

Access to resources Recommend Favorite

Normal in vivo skeletal muscle oxidative metabolism in sporadic inclusion body myositis assessed by 31 P-magnetic resonance spectroscopy

By Lodi R   Taylor DJ   Tabrizi SJ   Hilton-Jones D   Squier MV   Seller A   Styles P   Schapira AHV  

Brain, Vol. 121, Iss. 11, 1998-11 ,pp. : 2119-2126

Oxford University Press

Access to resources Recommend Favorite

Update on sporadic inclusion body myositis

By Hohlfeld Reinhard  

Brain, Vol. 134, Iss. 11, 2011-11 ,pp. : 3141-3145

Oxford University Press

Access to resources Recommend Favorite

Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis

By Dalakas Marinos C.  

Brain, Vol. 132, Iss. 6, 2009-06 ,pp. : 1536-1544

Oxford University Press

Access to resources Recommend Favorite